Page last updated: 2024-08-24

dexmedetomidine and Abdominal Aortic Aneurysm

dexmedetomidine has been researched along with Abdominal Aortic Aneurysm in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	2 (66.67)	2.80

Authors

Authors	Studies
Ergene, S; Hemsinli, D; Karakisi, SO; Mercantepe, T; Tumkaya, L; Yilmaz, A	1
Dai, M; Deng, J; Hu, R; Li, Q; Liu, Q; Yang, X; Yu, Q; Zhao, Y	1
Akada, S; Hongo, T; Okabe, T; Sakamoto, A; Takeda, S	1

Trials

1 trial(s) available for dexmedetomidine and Abdominal Aortic Aneurysm

Article	Year
Dexmedetomidine attenuates pneumocyte apoptosis and inflammation induced by aortic ischemia-reperfusion injury. Clinical and experimental hypertension (New York, N.Y. : 1993), 2022, Oct-03, Volume: 44, Issue:7 Topics: Adrenergic Agonists; Alveolar Epithelial Cells; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Apoptosis; Dexmedetomidine; Glutathione; Inflammation; Malondialdehyde; Rats; Rats, Sprague-Dawley; Reperfusion Injury	2022

Article

Year

Dexmedetomidine attenuates pneumocyte apoptosis and inflammation induced by aortic ischemia-reperfusion injury.

Clinical and experimental hypertension (New York, N.Y. : 1993), 2022, Oct-03, Volume: 44, Issue:7

Topics: Adrenergic Agonists; Alveolar Epithelial Cells; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Apoptosis; Dexmedetomidine; Glutathione; Inflammation; Malondialdehyde; Rats; Rats, Sprague-Dawley; Reperfusion Injury

2022

Other Studies

2 other study(ies) available for dexmedetomidine and Abdominal Aortic Aneurysm

Article	Year
Dexmedetomidine suppresses the development of abdominal aortic aneurysm by downregulating the mircoRNA‑21/PDCD 4 axis. International journal of molecular medicine, 2021, Volume: 47, Issue:5 Topics: Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Apoptosis Regulatory Proteins; Dexmedetomidine; Disease Models, Animal; Down-Regulation; Gene Expression Regulation; Genes, Reporter; Humans; Male; MicroRNAs; Rats; Rats, Sprague-Dawley	2021
Postoperative intensive care unit drug fever caused by dexmedetomidine. Anesthesia and analgesia, 2009, Volume: 108, Issue:5 Topics: Adrenergic alpha-Agonists; Aortic Aneurysm, Abdominal; Aortic Rupture; Blood Vessel Prosthesis Implantation; Body Temperature; Dexmedetomidine; Fever; Humans; Hypnotics and Sedatives; Intensive Care Units; Male; Middle Aged; Postoperative Care; Time Factors	2009

Article

Year

Dexmedetomidine suppresses the development of abdominal aortic aneurysm by downregulating the mircoRNA‑21/PDCD 4 axis.

International journal of molecular medicine, 2021, Volume: 47, Issue:5

Topics: Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Apoptosis Regulatory Proteins; Dexmedetomidine; Disease Models, Animal; Down-Regulation; Gene Expression Regulation; Genes, Reporter; Humans; Male; MicroRNAs; Rats; Rats, Sprague-Dawley

2021

Postoperative intensive care unit drug fever caused by dexmedetomidine.

Anesthesia and analgesia, 2009, Volume: 108, Issue:5

Topics: Adrenergic alpha-Agonists; Aortic Aneurysm, Abdominal; Aortic Rupture; Blood Vessel Prosthesis Implantation; Body Temperature; Dexmedetomidine; Fever; Humans; Hypnotics and Sedatives; Intensive Care Units; Male; Middle Aged; Postoperative Care; Time Factors

2009